Merry
Well-Known Member
An article published in Neuroscience News two days ago describes a discovery by scientists at Northwestern University that explains the mechanism that protects male mice from developing the lab mouse version of multiple sclerosis.
I liked this little detail about how a mistake led to progress in this research:
Using a mouse model of MS, they have identified a guardian molecule — triggered by testosterone — that appears to protect males from disease. When female mice with disease are treated with this protective molecule, their symptoms were eliminated. . . .
Northwestern scientists showed that testosterone caused mast cells, a type of immune cell, to produce the guardian molecule, cytokine IL-33, in male mice. The guardian molecule triggers a cascade of chemicals that prevents the development of another type of immune cell, so-called Th17 cells, that can directly attack the myelin.
In this model of disease, similar to MS in humans, females develop more of a disease-causing Th17 immune response than males. These Th17 cells, attack and destroy the myelin. But that damaging response was reversed in females by treatment with IL-33.
I liked this little detail about how a mistake led to progress in this research:
The discovery stemmed from an earlier lucky mistake in the lab in which male mice were used instead of female mice, because a graduate student hadn’t yet learned to identify the nearly imperceptible genitals of male mouse pups.
Last edited: